MERIT-HF - Description of the trial

Basic Research in Cardiology

Volumn 95, Issue 1 SUPPL., 2000, Pages

  Wikstrand, John ^a,b  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Beta blockade; Heart failure; Study desingn

Indexed keywords

EID: 0006664066     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s003950070016     Document Type: Article

References (14)

1. Australia/New Zealand Heart Failure Research Collaborative Group (1997) Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 349: 375-380
2. Califf RM, O'Connor CM (2000) β-blocker therapy for heart failure. The evidence is in, now the work begins. Editorial. JAMA 283: 1335-1337 (Pubitemid 30129803)
3. CIBIS-II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II (CIBIS II). Lancet 353: 9-13
4. Eichhorn EJ (1999) Beta-blockade withdrawal: the song of Orpheus. (Editorial). Am Heart J 138: 387-389 (Pubitemid 29428754)
5. Goldstein S, Kennedy HL, Hall C, Anderson JL, Gheorghiade M, Gottlieb S, Jessup M, Karlsberg RP, Friday G, Haskell L (1999) Metoprolol CR/XL in patients with heart failure: a pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction. Am Heart J 138: 1158-1165
6. Hjalmarson Å (2000) Basic Res Cardiol (Suppl) (this issue)
7. Hjalmarson Å, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus K-L, Jánosi A, Thorgeirsson G, Dunselman PHJM, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P for the MERIT-HF study Group (2000) Effects of controlled-release metoprolol on total mortality, hospitaliza-tions, and well-being in patients with heart failure. The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). JAMA 283: 1295-1302 (Pubitemid 30129796)
8. The International Steering Committee on behalf of the MERIT-HF Study Group (1997) Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). Am J Cardiol 80 (Suppl 9B): 54J-58J
9. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353: 2001-2007
10. Narang R, Cleland JGF, Erhardt L, Ball SG, Coats AJS, Cowley AJ et al. (1996) Mode of death in chronic heart failure. A request and proposition for more accurate classifi-cation. Eur Heart J 17: 1390-1403 (Pubitemid 26306668)
11. Packer, M, Bristow MR Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349-1355 (Pubitemid 26152713)
12. Rankin AC, Cobbe SM (1996) Arrhythmias and sudden death in heart failure: can we prevent them? In: McMurray JJV, Cleland JGF (eds) Heart Failure in Clinical Practice. Martin Dunitz Ltd, London, pp 189-205
13. Swedberg K, Hjalmarson Å, Waagstein F, Wallentin I (1980) Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J (b) 44: 134-142 (Pubitemid 10000988)
14. Waagstein F, Caidahl K, Wallentin I, Bergh C-H, Hjalmarson Å (1989) Long-term beta-blockade in congestive cardiomyopathy. Effects of acute and chronic metoprolol treatment followed by withdrawal and readmission of metoprolol. Circulation 80: 551-563 (Pubitemid 19231389)